Evidence map›Paper›PMID 33669344›Full record

ArticleGenes2021

Participation of TFIIIB Subunit Brf1 in Transcription Regulation in the Human Pathogen

Luis E Florencio-Martínez, Andrés Cano-Santiago, Fabiola Mondragón-Rosas, Maricarmen Gómez-García, Carlos Flores-Pérez, Fiordaliso C Román-Carraro, Luis A Barocio-Rodríguez, Rebeca G Manning-Cela, Tomás Nepomuceno-Mejía, Santiago Martínez-Calvillo

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Genes, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Molecular Response ofJournal of fungi (Basel, Switzerland) · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Luis E Florencio-MartínezUnidad de Biomedicina, Facultad de Estudios Superiores Iztacala, Universidad Nacional Autónoma de México. Av. de los Barrios 1, Col. Los Reyes Iztacala, Tlalnepantla, Edo. de Mexico, CP 54090, México.
Andrés Cano-SantiagoUnidad de Biomedicina, Facultad de Estudios Superiores Iztacala, Universidad Nacional Autónoma de México. Av. de los Barrios 1, Col. Los Reyes Iztacala, Tlalnepantla, Edo. de Mexico, CP 54090, México.
Fabiola Mondragón-RosasUnidad de Biomedicina, Facultad de Estudios Superiores Iztacala, Universidad Nacional Autónoma de México. Av. de los Barrios 1, Col. Los Reyes Iztacala, Tlalnepantla, Edo. de Mexico, CP 54090, México.
Maricarmen Gómez-GarcíaUnidad de Biomedicina, Facultad de Estudios Superiores Iztacala, Universidad Nacional Autónoma de México. Av. de los Barrios 1, Col. Los Reyes Iztacala, Tlalnepantla, Edo. de Mexico, CP 54090, México.
Carlos Flores-PérezUnidad de Biomedicina, Facultad de Estudios Superiores Iztacala, Universidad Nacional Autónoma de México. Av. de los Barrios 1, Col. Los Reyes Iztacala, Tlalnepantla, Edo. de Mexico, CP 54090, México.
Fiordaliso C Román-CarraroUnidad de Biomedicina, Facultad de Estudios Superiores Iztacala, Universidad Nacional Autónoma de México. Av. de los Barrios 1, Col. Los Reyes Iztacala, Tlalnepantla, Edo. de Mexico, CP 54090, México.
Luis A Barocio-RodríguezUnidad de Biomedicina, Facultad de Estudios Superiores Iztacala, Universidad Nacional Autónoma de México. Av. de los Barrios 1, Col. Los Reyes Iztacala, Tlalnepantla, Edo. de Mexico, CP 54090, México.
Rebeca G Manning-CelaDepartamento de Biomedicina Molecular, Centro de Investigación y de Estudios Avanzados del IPN, Av. IPN 2508, Ciudad de Mexico, CP 07360, México.
Tomás Nepomuceno-MejíaUnidad de Biomedicina, Facultad de Estudios Superiores Iztacala, Universidad Nacional Autónoma de México. Av. de los Barrios 1, Col. Los Reyes Iztacala, Tlalnepantla, Edo. de Mexico, CP 54090, México.
Santiago Martínez-CalvilloUnidad de Biomedicina, Facultad de Estudios Superiores Iztacala, Universidad Nacional Autónoma de México. Av. de los Barrios 1, Col. Los Reyes Iztacala, Tlalnepantla, Edo. de Mexico, CP 54090, México.ORCID 0000-0002-0247-7879
Autonomous University of Tlaxcala · MXInstituto Politécnico Nacional · MX

Funding

High performance Orbitrap Fusion Lumos mass spectrometer for proteomics and metabolomic researchS10OD023617 · OD · UPSTATE MEDICAL UNIVERSITY · PI KNUTSON, BRUCE ALAN · 2018 to 2018
$1.1M
NIH HHS S10 OD023617
6 · The paper itself

Abstract

In yeast and higher eukaryotes, transcription factor TFIIIB is required for accurate initiation of transcription by RNA Polymerase III (Pol III), which synthesizes transfer RNAs (tRNAs), 5S ribosomal RNA (rRNA), and other essential RNA molecules. TFIIIB is composed of three subunits: B double prime 1 (Bdp1), TATA-binding protein (TBP), and TFIIB-related factor 1 (Brf1). Here, we report the molecular characterization of Brf1 in

Indexed as

AnimalsGene Expression RegulationHumansLeishmania majorLeishmaniasis, CutaneousPromoter Regions, GeneticRNA Polymerase IIIRNA, Ribosomal, 18SRNA, Ribosomal, 5SRNA, Small NuclearSaccharomyces cerevisiaeTATA-Binding Protein Associated FactorsTranscription Factor TFIIIBTranscription, GeneticRNA Polymerase IIIRNA, Ribosomal, 18SRNA, Ribosomal, 5SRNA, Small NuclearTATA-Binding Protein Associated FactorsTranscription Factor TFIIIB5S rRNALeishmaniaPol III transcriptionRNA polymerasesTFIIIBtRNA

Identifiers

PMID33669344
PMCPMC7920299
OpenAlexW3132211791

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.